Journal article
Cancer stem cell research in Iran: potentials and challenges
Future oncology (London, England), Vol.13(20), pp.1809-1826
08/01/2017
DOI: 10.2217/fon-2017-0091
PMID: 28776391
Abstract
Treatment modalities can reduce cancer-related mortality; however, a majority of patients develop drug resistance, metastasis and relapse. It has been proposed that tumorigenic characteristics of tumors are related to a proportion of cancer cells, termed cancer stem cells (CSCs). Following the first evidence regarding the existence of CSC population in acute myeloid leukemia in 1997, publications in CSCs field showed an explosive trend in all cancer types around the world. First research paper in the field of CSCs in Iran was published in 2004 on prostate cancer. Subsequently, an annual number of publications in the field of CSCs displayed a rapidly growing trend. Therefore, in the current review, we have presented a comprehensive evaluation of the CSCs research in Iran.
Details
- Title: Subtitle
- Cancer stem cell research in Iran: potentials and challenges
- Creators
- Raheleh Roudi - Iran University of Medical SciencesMarzieh Ebrahimi - Royan InstituteAhmad Shariftabrizi - University at Buffalo, State University of New YorkZahra Madjd - Iran University of Medical Sciences
- Resource Type
- Journal article
- Publication Details
- Future oncology (London, England), Vol.13(20), pp.1809-1826
- Publisher
- Future Medicine Ltd
- DOI
- 10.2217/fon-2017-0091
- PMID
- 28776391
- ISSN
- 1479-6694
- eISSN
- 1744-8301
- Number of pages
- 18
- Language
- English
- Date published
- 08/01/2017
- Academic Unit
- Radiology
- Record Identifier
- 9984318811802771
Metrics
11 Record Views